HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D E Johnstone Selected Research

Apolipoproteins

1/2008Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D E Johnstone Research Topics

Disease

2Coronary Artery Disease (Coronary Atherosclerosis)
01/2008 - 10/2001
1Myocardial Infarction
01/2008

Drug/Important Bio-Agent (IBA)

1ApolipoproteinsIBA
01/2008
1Apolipoproteins B (ApoB)IBA
01/2008
1CholesterolIBA
01/2008
1HDL LipoproteinsIBA
01/2008
1Apolipoprotein A-I (Apolipoprotein A1)IBA
01/2008
1CX3C Chemokine Receptor 1IBA
01/2008
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
10/2001